MedPath
HSA Approval

AMINOVEN SOLUTION FOR INFUSION 10%

SIN11829P

AMINOVEN SOLUTION FOR INFUSION 10%

AMINOVEN SOLUTION FOR INFUSION 10%

February 28, 2002

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05BA01

amino acids

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI AUSTRIA GMBH

Active Ingredients

L-SERINE

6.500 g/1000 ml

Serine

GLYCINE

11.000 g/1000 ml

Glycine

L-LYSINE ACETATE EQV L-LYSINE

9.310 g/1000 ml

Lysine

L-METHIONINE

4.300 g/1000 ml

Methionine

L-TYROSINE

0.400 g/1000 ml

Tyrosine

TAURINE

1.000 g/1000 ml

Taurine

L-ISOLEUCINE

5.000 g/1000 ml

Isoleucine

L-PHENYLALANINE

5.100 g/1000 ml

Phenylalanine

L-VALINE

6.200 g/1000 ml

Valine

L-TRYPTOPHAN

2.000 g/1000 ml

Tryptophan

L-PROLINE

11.200 g/1000 ml

Proline

L-THREONINE

4.400 g/1000 ml

Threonine

L-HISTIDINE

3.000 g/1000 ml

Histidine

L-ARGININE

12.000 g/1000 ml

L-arginine

L-ALANINE

14.000 g/1000 ml

Alanine

LEUCINE

7.4 g/1000 ml

Leucine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMINOVEN SOLUTION FOR INFUSION 10% - HSA Approval | MedPath